Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2012

01-04-2012 | Letter to the Editor

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission

Authors: Maria Gueorguiev, Ashley B. Grossman

Published in: Endocrine | Issue 2/2012

Login to get access

Excerpt

To the Editor, …
Literature
1.
R.B. Barnes, D.A. Ehrmann, Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor. J. Clin. Endocrinol. Metab. 82, 1746–1748 (1997)PubMedCrossRef
2.
E.S. Vollaard, A.P. van Beek, F.A. Verburg, A. Roos, J.A. Land, Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin. J. Clin. Endocrinol. Metab. 96, 1197–1201 (2011)PubMedCrossRef
3.
Z. Efstathiadou, A. Tsatsoulis, Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist. Fertil. Steril. 75, 59–62 (2001)PubMedCrossRef
4.
B.A. Larson, W.P. Vanderlaan, H.L. Judd, D.L. McCullough, A testosterone-producing adrenal cortical adenoma in an elderly woman. J. Clin. Endocrinol. Metab. 42, 882–887 (1976)PubMedCrossRef
5.
G.A. Kaltsas, J.J. Mukherjee, B. Kola, A.M. Isidori, J.A. Hanson, J.E. Dacie, R. Reznek, J.P. Monson, A.B. Grossman, Is ovarian and adrenal venous catheterisation and sampling helpful in the investigation of hyperandrogenic women? Clin. Endocrinol. 59, 34–43 (2003)CrossRef
Metadata
Title
GnRH analogue use in postmenopausal hyperandrogenism: long-term remission
Authors
Maria Gueorguiev
Ashley B. Grossman
Publication date
01-04-2012
Publisher
Springer US
Published in
Endocrine / Issue 2/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9566-y

Other articles of this Issue 2/2012

Endocrine 2/2012 Go to the issue

Original Article

Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population

Mini Review

Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy

Original Article

Role of serum FSH measurement on bone resorption in postmenopausal women

Original Article

The source of leptin, but not leptin depletion in response to food restriction, changes during early pregnancy in mice

Original Article

An ontogenic study of adrenomedullin gene expression in the rat lung, adrenal, kidney, and heart

Letter to the Editor

Iatrogenic heart block during treatment of a patient with Cushing’s syndrome: report of a case
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits